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ing antibodies to c(1, (~3, and (xVI33 integrins as well as a non- 
blocking (z5131 antibody had no affect. MAP kinase activation 
was associated with increased phosphorylation of pyk2 but not 
focal adhesion kinase. Subsequent to MAP kinase activation 
increased phosphorylation of c-Jun and the NFkB inhibitor lkB 
was noted, followed by increased pro- and activated MMP-13 in 
the conditioned media. Inhibitors of MEK and p38 were both able 
to inhibit he increased MMP-13 production while the interleukin 
1 receptor antagonist protein did not. However, the IL-1 receptor 
antagonist partially inhibited fibronectin fragment induced activa- 
tion of MMP-13. 
Conclusion: These results suggest that disruption of chondro- 
cyte binding to a native matrix by a5bl blocking antibodies or 
fibronectin fragments stimulates integrin-mediated MAP kinase 
activation resulting in increased production and release of pro- 
and active MMP-13. Autocrine production of It_-I results in addi- 
"tional MMP-13 activation. 
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Aim: This study investigated the effect of oncostatin-M (OSM) on 
collagen degradation in explants of human articular cartilage. 
Methods: Monoclonat antibody (mAb) 2B4 was raised against a 
sequence from the C-telopeptide cross-linking domain of type 11 
collagen and recognizes a neoepitope of matrix metallopro- 
teinase cleavage. Full thickness plugs of human articular cartilage 
from the tibial plateau (banked tissue) or femoral condyle (surgi- 
cal amputation) were cultured in DMEM at 37°C in the presence 
or absence of recombinant human OSM (50 ng/ml) for up to 4 
weeks. Conditioned media were collected every 7 days and 
assayed for collagen fragments by competition ELISA based on 
mAb 2B4. Cartilage plugs were recovered after 1, 3 or 7 days of 
culture for immunohistochemical analysis using mAb 2B4. 
Results: Assay of the culture media showed elevated levels of 
2B4 epitope in OSM-treated cartilage plugs after 14 days of cul- 
ture (OSM-treated 29.8 ± 5.3 ng/ml vs control 15.5 ± 3.4 ng/ml, P 
= 0.006). By day 28, medium 2B4 epitope levels reached 208,0 
± 102.0 ng/ml for OSM-treated plugs compared with 39.0 _+.+ 7.0 
ng/ml for control plugs (P = 0.045). Cartilage plugs analyzed for 
2B4 epitope by immunohistochemistry showed strong pericellu- 
lar staining in plugs treated with OSM for 3 to 7 days. The 2B4 
signal was virtually absent from control plugs cultured without 
OSM, and from plugs cultured with OSM for tess than 3 days. 
Conclusion: OSM, a proinflammatory c tokine found in high lev- 
els in human rheumatoid synovial fluids, induces collagen degra- 
dation in human articular cartilage in vitro. Degraded collagen 
fragments are seen in the tissue after 3 to 7 days of OSM-treat- 
ment, sooner than reports of collagenase upregulation following 
cytokine stimulation. The findings support a concept that 
telopeptidase activity initiates collagen fibril degradation in this 
system. 
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Aim: The aim of this study was to assess the effects of ATP on 
the secretory profiles of prostanoids and the coupled signaling 
and enzymatic events in primary cultured monolayers of rabbit 
articular chondrocytes. ATP is an inflammatory mediator that is 
released from immune cell activation and damaged tissue at sites 
of inflammation. 
Results: ATP increased PGE2 release in a dose dependent fash- 
ion, with an activation threshold at 10 mM ATP and a 4.7-fold 
increase in PGE2 output at 100 mM ATP. ATP-induced PGE2 was 
detectable as soon as 2 rain, and reached maximum level at 1 
hour. Purinoceptor agonists stimulated PGE2 release by the 
chondrocytes with the following rank order of potency ATP = UTP 
ATPgS > ADR Adenosine was ineffective. The P2 receptor selec- 
tive antagonists suramin and reactive blue-2 inhibited ATP- 
induced PGE2 release. These results strongly suggest that ATP 
causes the release of PGE2 via the stimulation of P2Y receptors. 
Furthermore, extracellular nucleotides stimulated a rapid, tran- 
sient and concentration-dependent activation of stress- and 
mitogen activated protein kinases (SAPK and MAPK), respective- 
ly p38 and ERKI/2, as measured by phosphorylation of the both 
kinases. The activation of p38 kinase and ERKI/2 by ATP and UTP 
was dose dependently attenuated by suramin. 
To understand the enzymatic cascade implicated in the ATP 
dependent PGE2 release, we first tested AACOCF3, an inhibitor 
of cPLA2 and BEL, an inhibitor of the iPLA2. The response 
induced by ATP was not affected by BEL and completely blocked 
by AACOCF3, suggesting that cPLA2 mediated the release of 
PGE2 in response to purinergic agonists. A complete blockade of 
the ATP-induced PGE2 release was observed with each inhibitor 
of the MAPKinases PD 98059 and 5B203580. In contrast, the 
release of arachidonic acid in response to ATP was only affected 
by PD 98059, suggesting that cPLA2 activation was mediated 
through activation of the ERKI/2 MAPKinase. The following enzy- 
matic events were investigated with the use of NS-398, a selec- 
tive COX-2 and PGE-synthase inhibitor and SC-560, a selective 
COX-1 inhibitor. Both of them prevented ATP-induced PGE2 
release. 
Conclusion: We conclude that extracellular ATP, acting via P2Y- 
purinoceptors, stimulates PGE2 release from articular chondro- 
cytes and thus may have physiological and pathological effects 
in articular cartilage. 
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Aim: The aim of this study was to track the process of aggre- 
canolysis in intact bovine articular cartilage (BAC) induced by 
recombinant human interleukin-lb (IL-1) or by the action of 
recombinant human aggrecanase-1 (rhAgg-1) in vitro using 
immunocytocheimcal methods. 
